Yasu Takeuchi

965 total citations
12 papers, 314 citations indexed

About

Yasu Takeuchi is a scholar working on Infectious Diseases, Genetics and Molecular Biology. According to data from OpenAlex, Yasu Takeuchi has authored 12 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Yasu Takeuchi's work include Virus-based gene therapy research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Yasu Takeuchi is often cited by papers focused on Virus-based gene therapy research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Yasu Takeuchi collaborates with scholars based in United Kingdom, United States and India. Yasu Takeuchi's co-authors include Chris Boshoff, Andrew Godfrey, John Anderson, Linda Scobie, Christopher Perry, Daniel G. Bracewell, Joachim Denner, Jay A. Fishman, Ralf R. Tönjes and Mark O. Clements and has published in prestigious journals such as Blood, Journal of Virology and Biotechnology and Bioengineering.

In The Last Decade

Yasu Takeuchi

12 papers receiving 310 citations

Peers

Countries citing papers authored by Yasu Takeuchi

Since Specialization

Citations

This map shows the geographic impact of Yasu Takeuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasu Takeuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasu Takeuchi more than expected).

Fields of papers citing papers by Yasu Takeuchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasu Takeuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasu Takeuchi. The network helps show where Yasu Takeuchi may publish in the future.

Co-authorship network of co-authors of Yasu Takeuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasu Takeuchi. A scholar is included among the top collaborators of Yasu Takeuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasu Takeuchi. Yasu Takeuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Insights into product and process related challenges of lentiviral vector bioprocessing 2023 ·Biotechnology and Bioengineering ·Christopher Perry, (unknown), Yasu Takeuchi, (unknown)	10
2	Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike 2021 ·BIO-PROTOCOL ·Leila Mekkaoui, Emma Bentley, Mathieu Ferrari, (unknown), (unknown), (unknown), (unknown), Reyisa Bughda, James Sillibourne, Shimobi Onuoha, Giada Mattiuzzo, Yasu Takeuchi, Martin Pulé	3
3	Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy 2021 ·Biomolecules ·(unknown), Yasu Takeuchi, Othmar G. Engelhardt, Simon E. Hufton	8
4	Lentiviral Vector Purification Using Nanofiber Ion-Exchange Chromatography 2019 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Christopher Perry, (unknown), Yasu Takeuchi, Daniel G. Bracewell	34
5	PERVading strategies and infectious risk for clinical xenotransplantation 2018 ·Xenotransplantation ·Christopher G.A. McGregor, Yasu Takeuchi, Linda Scobie, Guerard W. Byrne	15
6	First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes—Chapter 5: recipient monitoring and response plan for preventing disease transmission 2016 ·Xenotransplantation ·Joachim Denner, Ralf R. Tönjes, Yasu Takeuchi, Jay A. Fishman, Linda Scobie	32
7	Antibiotic susceptibility and resistance of Staphylococcus aureus isolated from fresh porcine skin xenografts: Risk to recipients with thermal injury 2013 ·Burns ·(unknown), Andrew Robb, Sue Lang, Yasu Takeuchi, Pavel Veselý, Linda Scobie	5
8	Suggestions for the diagnosis and elimination of hepatitis E virus in pigs used for xenotransplantation 2013 ·Xenotransplantation ·(unknown), Claire Crossan, Jon Godwin, Björn Petersen, Cesare Galli, Emanuele Cozzi, Yasu Takeuchi, Linda Scobie	13
9	PERV-C integration, expression and transmission of PERV to human cells 2011 ·UCL Discovery (University College London) ·Linda Scobie, Ralph D. Hector, (unknown), Juan M. Ribes, Giada Mattiuzzo, Claire Crossan, Jiřı́ Hejnar, Yasu Takeuchi	1
10	Kaposi's Sarcoma-Associated Herpesvirus vFLIP and Human T Cell Lymphotropic Virus Type 1 Tax Oncogenic Proteins Activate IκB Kinase Subunit γ by Different Mechanisms Independent of the Physiological Cytokine-Induced Pathways 2011 ·Journal of Virology ·Akira Shimizu, Mehdi Baratchian, Yasu Takeuchi, David Escors, Douglas MacDonald, Tracey Barrett, Claire Bagnéris, Mary Collins, Mahdad Noursadeghi	15
11	Lentiviral Manipulation of Gene Expression in Human Adult and Embryonic Stem Cells 2006 ·Tissue Engineering ·Mark O. Clements, Andrew Godfrey, (unknown), Sam J. Wilson, Yasu Takeuchi, Chris Boshoff	30
12	Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA 2004 ·Blood ·Andrew Godfrey, John Anderson, (unknown), Yasu Takeuchi, Chris Boshoff	148

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact